Efficient TALEN-mediated gene knockout in livestock
- PMID: 23027955
- PMCID: PMC3491456
- DOI: 10.1073/pnas.1211446109
Efficient TALEN-mediated gene knockout in livestock
Abstract
Transcription activator-like effector nucleases (TALENs) are programmable nucleases that join FokI endonuclease with the modular DNA-binding domain of TALEs. Although zinc-finger nucleases enable a variety of genome modifications, their application to genetic engineering of livestock has been slowed by technical limitations of embryo-injection, culture of primary cells, and difficulty in producing reliable reagents with a limited budget. In contrast, we found that TALENs could easily be manufactured and that over half (23/36, 64%) demonstrate high activity in primary cells. Cytoplasmic injections of TALEN mRNAs into livestock zygotes were capable of inducing gene KO in up to 75% of embryos analyzed, a portion of which harbored biallelic modification. We also developed a simple transposon coselection strategy for TALEN-mediated gene modification in primary fibroblasts that enabled both enrichment for modified cells and efficient isolation of modified colonies. Coselection after treatment with a single TALEN-pair enabled isolation of colonies with mono- and biallelic modification in up to 54% and 17% of colonies, respectively. Coselection after treatment with two TALEN-pairs directed against the same chromosome enabled the isolation of colonies harboring large chromosomal deletions and inversions (10% and 4% of colonies, respectively). TALEN-modified Ossabaw swine fetal fibroblasts were effective nuclear donors for cloning, resulting in the creation of miniature swine containing mono- and biallelic mutations of the LDL receptor gene as models of familial hypercholesterolemia. TALENs thus appear to represent a highly facile platform for the modification of livestock genomes for both biomedical and agricultural applications.
Conflict of interest statement
Conflict of interest statement: S.C.F. is an executive and shareholder in Recombinetics, Inc., a company focused on the commercialization of transcription activator-like effector nucleases for livestock biomedical and agricultural applications. D.F.C. is an employee and shareholder of Recombinetics, Inc.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- BBS/E/D/05251442/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BBS/E/D/05251443/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BBS/E/D/07731442/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- 1R41HL108440-01/HL/NHLBI NIH HHS/United States
- BBS/E/D/05251445/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
